Skip to main content
logo
Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
192.00
0.00 (0.00%)
Sep 2, 2026, 9:37 AM HKT

HKG:2637 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
593.9582.36466.68316.63212.47
Revenue Growth
87.57%24.79%47.39%49.03%-
Gross Profit
481.25485.56387.19263.64172.07
Operating Income
177.47192.26133.03120.2880.35
Net Income
150.27177.03136.08117.4568.98
Earnings Per Share
2.002.552.021.751.07
EPS Growth
14.40%25.79%15.86%62.83%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
1,1911,330273.24274.6312.17
Total Debt
80.8110.1556.8850.0992.18
Net Cash (Debt)
1,1111,220216.36224.51219.99
Net Cash Growth
394.67%464.03%-3.63%2.05%-
Net Cash Per Share
14.7817.563.223.343.42

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-159.88163.94147.1185.31
Capital Expenditures
--44.79-178.56-58.71-3.07
Free Cash Flow
-115.09-14.6288.3982.24
Free Cash Flow Growth
---7.47%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
81.03%83.38%82.97%83.26%80.99%
Operating Margin
29.88%33.01%28.51%37.99%37.82%
Pretax Margin
26.85%34.01%31.93%41.95%34.72%
Profit Margin
25.30%30.40%29.16%37.09%32.47%
FCF Margin
-19.76%-3.13%27.92%38.71%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
83.1854.34---
P/FCF Ratio
-83.58---
PS Ratio
22.0416.52---